Nadolol: a new beta-blocker that may increase patient compliance.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D009248:Nadolol; D010349:Patient Compliance; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol